Home / Fact sheets / Greece / Colorectal qualitative data
Check also the following factsheets: Greece, Breast, Cervical
Country fact sheet: Greece
COLORECTAL CANCER SCREENING PROGRAMME
Reporting year for qualitative data: | 2016 |
Source of qualitative data: | Other (EU Report 2017) |
Organization of screening | |
An individual/team/institution responsible to coordinate the programme: | - |
Dedicated budget for screening programme: | - |
Documented cancer screening policy: | Yes |
Nature of documentation of the policy: | Recommendation |
Year programme was initiated: | No data submitted |
Programme introduction was preceded by a pilot: | - |
Screening tests provided free of charge: | - |
Diagnostic tests provided free of charge: | - |
Treatment services provided free of charge: | - |
Information system and data collection | |
System that collects data: | |
• Identification of eligible population: | - |
• Screening participation: | - |
• Screening test results: | - |
• Further assessment: | - |
• Final pathology diagnosis: | - |
• Cancer staging: | - |
• Treatment: | - |
The information system exists at national or sub-national level: | Individual: Unknown Aggregated: Unknown |
The information system collects data outside the programme (opportunistic screening/private sector): | - |
Cancer screening data is linked with population-based cancer registry (PBCR): | - |
Screening protocol | |
A screening protocol or guideline: | - |
Year of published/updated protocol: | - |
Target age (min-max) and screening interval [months] for each test: | gFOBT (50-70 years / [24 months]) Colonoscopy (50-70 years / [60 months]) |
Invitations for screening and further assessment | |
Initiatives to create population awareness by the Health Ministry/Health Authority: | - |
Invitations to eligible population: | - |
Source of the eligible individuals identified: | - |
Method of invitation: | - |
Screening kit included with the invitation: | - |
Screen positive individuals actively contacted for further assessment: | - |
Individuals with a precancer or cancer diagnosis actively contacted: | - |
Quality Assurance (QA) of screening activities | |
Documented standard operating procedure/policy for QA: | - |
An individual/team/institution responsible for QA: | - |
Accreditation of endoscopy units: | - |
Accreditation of pathology services: | - |
Documented performance indicators: | - |
Reference standards for performance indicators: | - |
Evaluation reports published in the last five years: | - |
Performance indicators | |
Reporting year for quantitative data: | 2016 |
Source of quantitative data: | Report (EU Report 2017) |
FIT | gFOBT | Sigmoidoscopy | Colonoscopy | |
Target age and regional limitation if applicable: | ||||
Invitation coverage (%): | ||||
Participation rate (%): | ||||
Examination coverage (%): | ||||
Completeness of data related to screening results (%): | ||||
Completeness of data related to information about attendance to colonoscopy assessment (%): | ||||
Further assessment (diagnosis colonoscopy) rate (%): | ||||
Further assessment participation rate (%): | ||||
Detection rate of adenomas (x 1000): | ||||
Detection rate of advanced adenomas (x 1000): | ||||
Detection rate of colorectal cancers (x 1000): | ||||
Positive Predictive Value of further assessment to detect adenomas (%): | ||||
Positive Predictive Value of further assessment to detect advanced adenomas (%): | ||||
Positive Predictive Value of further assessment to detect colorectal cancers (%): |
Check also the following factsheets: Greece, Breast, Cervical